share_log

Credit Suisse Trims Acumen Pharmaceuticals' Price Target to $16 From $17, Keeps Outperform Rating

Credit Suisse Trims Acumen Pharmaceuticals' Price Target to $16 From $17, Keeps Outperform Rating

瑞士信貸將Acumen PharmPharmticals的目標價從17美元下調至16美元,保持表現優於評級
MT Newswires ·  2022/11/15 10:01

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論